Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
TSC22D4 regulates hepatic lipoprotein production, but has so far mainly been studied in the context of cancer cachexia. Here, the authors show TSC22D4 inhibition improves insulin sensitivity in several mouse models of diabetes, which they attribute at least in part to the induction of secreted LCN13...
Main Authors: | Bilgen Ekim Üstünel, Kilian Friedrich, Adriano Maida, Xiaoyue Wang, Anja Krones-Herzig, Oksana Seibert, Anke Sommerfeld, Allan Jones, Tjeerd P. Sijmonsma, Carsten Sticht, Norbert Gretz, Thomas Fleming, Peter P. Nawroth, Wolfgang Stremmel, Adam J. Rose, Mauricio Berriel-Diaz, Matthias Blüher, Stephan Herzig |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms13267 |
Similar Items
-
Emerging Targets in Type 2 Diabetes and Diabetic Complications
by: Sevgican Demir, et al.
Published: (2021-09-01) -
A Hepatic GAbp-AMPK Axis Links Inflammatory Signaling to Systemic Vascular Damage
by: Katharina Niopek, et al.
Published: (2017-08-01) -
Brown adipose tissue harbors a distinct sub-population of regulatory T cells.
by: Dasa Medrikova, et al.
Published: (2015-01-01) -
A Glyoxalase-1 Knockdown Does Not Have Major Short Term Effects on Energy Expenditure and Atherosclerosis in Mice
by: Markus Wortmann, et al.
Published: (2016-01-01) -
Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function
by: Blüher, M., et al.
Published: (2022)